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Background: Previous findings suggested that Lactobacillus rhamnosus CRL1505 is able to increase resistance of
children to intestinal viral infections. However, the intestinal cells, cytokines and receptors involved in the
immunoregulatory effect of this probiotic strain have not been fully characterized.
Results: We aimed to gain insight into the mechanisms involved in the immunomodulatory effect of the CRL1505
strain and therefore evaluated in vitro the crosstalk between L. rhamnosus CRL1505, porcine intestinal epithelial cells
(IECs) and antigen presenting cells (APCs) from swine Peyer’s patches in order to deepen our knowledge about the
mechanisms, through which this strain may help preventing viral diarrhoea episodes. L. rhamnosus CRL1505 was
able to induce IFN–α and –β in IECs and improve the production of type I IFNs in response to poly(I:C) challenge
independently of Toll-like receptor (TLR)-2 or TLR9 signalling. In addition, the CRL1505 strain induced mRNA
expression of IL-6 and TNF-α via TLR2 in IECs. Furthermore, the strain significantly increased surface molecules
expression and cytokine production in intestinal APCs. The improved Th1 response induced by L. rhamnosus CRL1505
was triggered by TLR2 signalling and included augmented expression of MHC-II and co-stimulatory molecules and
expression of IL-1β, IL-6, and IFN-γ in APCs. IL-10 was also significantly up-regulated by CRL1505 in APCs.
Conclusions: It was recently reviewed the emergence of TLR agonists as new ways to transform antiviral treatments
by introducing panviral therapeutics with less adverse effects than IFN therapies. The use of L. rhamnosus CRL1505 as
modulator of innate immunity and inductor of antiviral type I IFNs, IFN-γ, and regulatory IL-10 clearly offers the potential
to overcome this challenge.
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due to preventable infectious diseases like pneumonia and
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of severe dehydrating diarrhoea in children worldwide
[3,4]. Although there is already a successful rotavirus vac-
cine in the market, the epidemic in the developing world
is far from being controlled [4,5]. Apart from being not af-
fordable for low-income population groups, it has also
been shown that protection induced by natural infection
and vaccination is reduced in developing areas, where
among other factors, children are infected at an early age
and high viral challenge loads are usual [6]. Moreover,
Latin America in general and northern Argentina in par-
ticular, presents a significant population of malnourishedLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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able infectious diseases such as rotavirus infections [2].
Several studies have demonstrated that certain lactic
acid bacteria (LAB) strains can exert their beneficial effect
on the host through their immunomodulatory activity. In
this sense, some studies have centred on whether immu-
noregulatory probiotic LAB (immunobiotics) might suffi-
ciently stimulate the intestinal immune system to provide
protection against viral infections. It was reported that
probiotics can exerts some beneficial effects in rotavirus
intestinal infections such as shortening the duration of
diarrhoea, reducing the number of episodes, lessening
rotavirus shedding, normalizing gut permeability and in-
creasing the production of rotavirus-specific antibodies
[7-9]. In an attempt to find low-cost alternatives for the
prevention of infectious diseases we have developed a new
probiotic yogurt, containing the immunobiotic strain
Lactobacillus rhamnosus CRL1505, able to improve resis-
tance against respiratory and intestinal infections. Our
studies in animal models showed that the administration
of L. rhamnosus CRL1505 significantly augmented the re-
sistance of immunocompetent and immunocompromised
malnourished mice to intestinal and respiratory pathogens
such as Salmonella Typhimurium and Streptococcus pneu-
moniae [10,11]. In addition, we performed a randomized
controlled trial in order to evaluate the effect of the pro-
biotic yogurt containing L. rhamnosus CRL1505 on both
gut and non-gut related illnesses among children [12]. We
demonstrated that the CRL1505 strain improved mucosal
immunity and reduced the incidence and severity of intes-
tinal and respiratory infections. We registered that 34% of
the children who consumed the probiotic yogurt showed
some type of infectious event, while in the placebo group
this value was higher reaching a 66% of them. Although
we did not evaluate aetiology of intestinal and respiratory
infections in the clinical study, previous evaluations have
shown that viruses, such as rotavirus and respiratory syn-
cytial virus, are the major pathogens, which cause infec-
tious diseases in children in northern Argentina [13,14].
Therefore, our findings suggested that administration of
L. rhamnosus CRL1505 may provide a potential interven-
tion to prevent the course of common childhood viral in-
fections. Some of the mechanisms by which L. rhamnosus
CRL1505 exerts its immunomodulatory and antiviral
properties have been elucidated [10,11,15]. We have re-
cently showed the capacity of the CRL1505 strain to im-
prove the production of antiviral cytokines in the gut and
the respiratory tract [10,11,15,16]. However, the intestinal
cells, cytokines and receptors involved in the immunore-
gulatory effect of this immunobiotic strain have not been
fully characterized.
Intestinal epithelial cells (IECs) are the first cells which en-
counter exogenous and endogenous as well as pathogenic
and non-pathogenic microorganisms [17]. In addition, thegut of vertebrates is rich in antigen-presenting cells (APCs),
such as macrophages and dendritic cells (DCs), which are
able to recognize foreign antigens or invading pathogens.
The epithelium and APCs at the intestinal surfaces express
a diverse range of Pattern Recognition Receptors (PRRs)
capable of detecting viruses. Epithelial- and APCs-ex-
pressed PRRs include cell surface expressed C-type lectins
(cell surface variants of the secreted collectins), intra- and
extracellular toll-like receptors (TLR), the intracellular
RNA-dependent protein kinase (PKR), retinoic acid–indu-
cible gene I (RIG-I) like receptors (RLR) and nucleotide
binding domain and leucine-rich repeat containing recep-
tors (NLR) [18-20]. Upon recognition of double-stranded
RNA (dsRNA) or its synthetic analogue poly(I:C), TLR3
and RIG-I trigger the activation of the transcription factors
IRF-3, NF-kB, and AP-1, which in turn induce type I IFNs
(especially IFN-β) and cytokine/chemokine synthesis.
There is a growing interest in studying the swine immune
system because of its similarities to the human immune
system. We have precisely characterized the functionality of
porcine APCs from Peyer’s Patches (PPs) before and also
demonstrated that swine PPs-derived adherent cells are a
useful in vitro tool for investigating innate responses to
pathogenic and probiotic microorganisms [21]. In addition,
we have also reported an abundant intracellular expression
of TLR3 in a porcine intestinal epithelial (PIE) cell line [22],
which is in line with findings of Liu et al. [8] that demon-
strated that the non-transformed porcine jejunum epithelial
cell line (IPEC-J2) expresses TLR3 constitutively. We char-
acterized the immune response triggered by poly(I:C) chal-
lenge in PIE cells and in PIE-immune cell co-cultures, and
demonstrated that these systems are valuable tools for
studying in vitro the immune response triggered by TLR3/
RIG-I on IECs and the interaction between IECs and im-
mune cells [22,23]. In this study, we therefore aimed to use
these porcine in vitro systems to gain insight into the
mechanisms involved in the immunomodulatory effect of
CRL1505 strain, and concentrated our attention in the
crosstalk between L. rhamnosus CRL1505, PIE cells and
APCs in order to deepen our knowledge about the mecha-
nisms, through which this strain may help preventing viral
diarrhoea episodes.Methods
Microorganisms
Lactobacillus rhamnosus CRL1505 (Lr1505) and L. rham-
nosus CRL1506 (Lr1506) belong to CERELA Culture Col-
lection and were originally isolated from goat milk [11].
These strains were grown in Man-Rogosa-Sharpe (MRS)
broth at 37°C. For immunomodulatory assays, overnight
cultures were harvested by centrifugation, washed three
times with sterile PBS, counted in a Petroff-Hausser coun-
ting chamber, and re-suspended in DMEM until use.
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A non-transformed porcine intestinal epithelial cell line
(PIE), characterized by its ability to build a monolayer with
a cobblestone and epithelial-like morphology and close
contacts between cells was used as described before
[22,23]. Briefly, PIE cells were grown on type I collagen-
coated dishes using DMEM (Gibco, Japan) supplemented
with 10% fetal calb serum (FCS, Sigma). PIE cells were in-
cubated at 37°C and 5% CO2. Passages were done by treat-
ing the monolayer with sucrose/EDTA for 4 min and
detaching the cells with 0.04% trypsin.
Isolation of adherent population from swine Peyer’s
patches (PPs)
Suspensions of porcine PP immunocompetent cells were
prepared from adult swine intestine. This study was car-
ried out in strict accordance with the recommendations in
the Guide for the Care and Use of Laboratory Animals of
the Guidelines for Animal Experimentation of Tohoku
University, Sendai, Japan. The present study was approved
by the Institution Animal Care and Use Committee of
Tohoku University with a permitted No. 2011-noudou-5
and all efforts were made to minimize suffering. Swine
PPs were cut into small pieces and gently pressed through
a nylon mesh to prepare single immune cell suspensions.
After several washes in complete RPMI medium, residual
erythrocytes were lysed in 0.2% NaCl followed by a hy-
pertonic rescue in 1.5% NaCl. Finally, immune cells
were fractioned by density gradient centrifugation using
Lympholyte Mammal (Cedarlane, Corby, Canada) and the
mononuclear cell suspension containing a mixed popula-
tion of T, B and antigen presenting cells (APCs) was sus-
pended in complete DMEM supplemented with 10% FCS,
50 μg/ml penicillin/streptomycin and 50 μg/ml gentamy-
cin (Nacalai Tesque, Kyoto, Japan) [22,23]. APCs (macro-
phages and DCs) were separated by their ability to adhere
to glass as described before [21]. Briefly, cell sus-
pensions (5 × 107 cells/well) were placed onto 2-well
glass plates (Iwaki, Tokyo, Japan) and incubated for 2 h
at 37°C and 5% CO2 to allow cells to adhere to the glass
surface. Subsequently, they were washed gently with
complete RPMI 1640 medium (Sigma) to remove non-
adherent cells. With this methodology a mix population
containing CD172a+CD11R1−, CD172a−CD11R1low and
CD172a+CD11R1high cells was obtained [21].
Immunomodulatory effect of lactobacilli
Evaluation of the immunomodulatory activity of L.
rhamnosus CRL1505 and L. rhamnosus CRL1506 was
performed using PIE cells and PPs-derived adherent cells
[21-23]. For immunomodulatory assays, 1.5 × 104 PIE
cells/well were plated onto type I collagen coated 24-
well plates (Iwaki, Tokyo, Japan). Three days later, cell
monolayers were washed, added with lactobacilli (5 ×108 cells/well) and incubated for 48 h at 37°C and 5%
CO2, after which cells were vigorously washed and har-
vested for total RNA isolation for cytokine expression
profiles. In a second experiment to study immunomo-
dulation of antiviral innate responses with lactobacilli,
PIE cell monolayers were incubated 48 h with lactoba-
cilli, washed three times to eliminate possible stimulants
and were further stimulated with poly(I:C) to mimic
viral infection at the indicated times. Again, RNA was
isolated for studying expression profiles [22,23]. Adher-
ent cells were plated at a density of 1.5 × 106 cells/well
in 12-well type I collagen-coated plates (Iwaki) or in 2-
well glass plates (Iwaki). Lactobacilli were added to each
well (5 × 108 cells/ml) and incubated for further 16 h.
For evaluation of the modulation of antiviral responses
by lactobacilli in APCs, adherent cells were prepared as
indicated before and 16 h later, each well was washed
vigorously with medium at least 3 times to eliminate
bacteria; and finally the porcine cells were stimulated
with poly(I:C) for the time indicated [21]. In addition,
unlabelled anti-TLR2 rabbit IgG or anti-TLR9 rabbit
IgG (Santa Cruz, Santa Cruz, CA) were used in blocking
experiments. Cultured cells were incubated with the un-
labelled anti-TLR2 or anti-TLR9 antibodies for 12 h be-
fore stimulation with lactobacilli.
Lactobacilli immunomodulatory activity in PIE-adherent
cells co-culture system
Porcine PPs adherent cells suspensions were prepared as
described above. In the Transwell culture system, PIE cells
were seeded in the apical surface at a concentration of
1.5 × 105 cells/well in 12-well tissue culture plates (Trans-
well-Col. (PTFE), pore size 0.2 mm) while porcine PPs ad-
herent cells were seeded in the basolateral compartment
at a concentration of 2 × 107 cells/well [22,23]. For the
evaluation of the immunomodulatory activity of lactoba-
cilli in the PIE-immune cell co-culture system, the apical
surface containing PIE cells was stimulated with lactoba-
cilli strains for 48 h and then washed twice with PBS. Fi-
nally, PIE cells were stimulated with poly(I:C) for 12 h.
qRT-PCR of mRNA expression in PIE and immune cells
Total RNA from each stimulated monolayer (PIE cell
monoculture or co-culture) was isolated using TRIzol
reagent (Invitrogen) according to the manufacturer’s in-
structions. cDNA was synthesized using a Quantitect
Reverse Transcription kit (Qiagen, Tokyo, Japan). qRT-
PCR was carried out in a 7300 Real-time PCR System
(Applied Biosystems, Warrington, Cheshire, UK) using
Platinum SYBR Green qPCR SuperMix UDG with ROX
(Invitrogen). The primers for IFN-α, IFN-β, TNF-α,
IFN-γ, IL-1β, TGF-β, IL-2, IL-6, IL-10 and IL-12p40
used in this study were described previously [24]. The
PCR cycling conditions were 5 min at 50°C; followed by
Villena et al. BMC Microbiology 2014, 14:126 Page 4 of 14
http://www.biomedcentral.com/1471-2180/14/1262 min at 95°C; then 40 cycles of 15 sec at 95°C, 30 sec at
60°C and 30 sec at 72°C. The reaction mixture con-
tained 5 μl cDNA and 15 μl master mix including sense
and antisense primers. Expression of the house-keeping
gene b-actin was assessed in each sample, as an internal
control to normalize differences between samples and
to calculate the relative index.
Flow cytometric analysis
Flow cytometry was used to assess expression of MHC-II,
CD80/86, IFN-γ, IL-1β, IL-6 and IL-10 in PPs CD172
a+CD11R1−, CD172a−CD11R1low and CD172a+CD11R1high
cells. Adherent cells were isolated as described above and
labeled with primary antibodies: anti-porcine CD172a-PE
SWC3 IgG1 (Southern Biotech), anti-porcine CD11R1-
IgG1 (AbD Serotec), anti-porcine MHC-II-IgG2a (VMRD),
anti-porcine gamma interferon (IFN-γ)-IgG2b (R&D
Systems, Minneapolis, MN), anti-porcine interleukin-10
(IL-10)-IgG2b (R&D Systems), anti-porcine IL-1β/IL-1 F2-
IgG1 (R&D Systems), and anti-porcine IL-6-IgG2b (R&D
Systems). The binding of unlabeled monoclonal antibodies
was visualized using the following secondary antibodies:
anti-mouse IgG1-peridinin chlorophyll protein (PerCP)/
Cy5.5 (Bio Legend, San Diego, CA), anti-mouse IgG2a-
FITC (AbD Serotec), anti-rabbit IgG-Alexa Fluor 489
(Santa Cruz), anti-mouse IgG2b-FITC (AbD Serotec), and
anti-mouse IgG-FITC (AbD Serotec) [21]. In addition, ex-
pression levels of CD80/86 proteins were evaluated using a
human CD152 (cytotoxic-T- lymphocyte-associated anti-
gen 4) Ig/FITC fusion protein (Ancell, Bay- port, MN).
Cells stained with irrelevant mouse IgG-FITC, IgG2b-
FITC, IgG2a-PerCP, IgG2b-PE, IgG2a-PE, or IgG1-PE anti-
bodies (eBioscience, San Diego, CA) were included as
isotype controls. Analysis of the stained cells was per-
formed using a FACSCalibur flow cytometer (BD, Franklin
Lakes, NJ), which was equipped with Cell-Quest software.
Data analysis was performed using FlowJo software (Tree
Star, Ashland, OR) [21].
Statistical analysis
Statistical analyses were performed using the GLM and
REG procedures available in the SAS computer program
(SAS, 1994). Comparisons between mean values were car-
ried out using one-way analysis of variance and Fisher’s
least-significant-difference (LSD) test. P < 0.05 were con-
sidered significant.
Results
Lactobacillus rhamnosus strains differentially modulate
cytokines transcriptional profiles of PIE cells and PPs
derived adherent cells
The first aim of this study was to evaluate the effect of
Lr1505 on the cytokine mRNA expression profile of PIE
cells and PPs adherent cells. In addition, we used asecond strain, Lr1506, also isolated from goat milk, to
comparatively evaluate their effects. Both lactobacilli
have similar technological properties and the ability to
improve intestinal immunity [11,16]. However, Lr1506 is
not able to improve respiratory immunity when orally
administered, therefore comparative studies with both
Lr1505 and Lr1506 offer a unique opportunity to study
the mechanisms involved in the immunoregulatory ef-
fects of probiotics. Hence, PIE cell monolayers were
stimulated with Lr1505 or Lr1506 for 48 h and the ex-
pression of several cytokines was quantified by qRT-PCR
(Figure 1A). The expression levels of mRNA coding for
IFN-α, IFN-β, IL-6 and TNF-α were significantly in-
creased by both lactobacilli strains (Figure 1A). Further-
more, while TNF-α and IL-6 mRNAs were up-regulated
to similar levels by both strains, the up-regulation of
both IFN-α and IFN-β by Lr1506 was significantly
higher than those induced by Lr1505 (Figure 1A). In
addition, MCP-1 mRNA expression remained unchanged
for all treatments.
In a similar setting but using APCs, Lr1505 and
Lr1506 also showed a differential effect on the mRNA
expression of some cytokines as shown in Figure 1B. Al-
though both strains stimulated adherent cells, Lr1505
showed a stronger enhancing influence than Lr1506 on
the expression of mRNA coding for IL-1β, IFN-γ, IL-2,
IL-12 and IL-10 (Figure 1B). Both lactobacilli slightly
but significantly increased the mRNA synthesis of IL-6
and TNF-α to similar levels. In contrast to the results
seen in PIE cells, there was no meaningful effect on the
mRNA expression of type I IFN (Figure 1B). Further-
more, TGF-β mRNA levels were not affected by the
stimulation with lactobacilli.
L. rhamnosus CRL1505 and CRL1506 stimulate PPs APCs
and distinctly modulate cytokine production
We next studied whether Lr1505 and Lr1506 were able
to affect the expression of two cellular surface markers
for APCs activation: MHC-II and CD80/CD86. Adher-
ent cells isolated from swine Peyer’s Patches can be
grouped as CD172a+CD11R1high, CD172a−CD11R1low
and CD172a+CD11R1− cells [21]. Although more detailed
functional studies are needed to accurately define each
population, it has been suggested that CD172a+CD11R1high
and CD172a−CD11R1low cells could be considered as DCs
and CD172a+CD11R1− cells could be considered as macro-
phages [21]. In these three cell populations, both strains
exerted an up-regulation of the antigen presenting and co-
stimulatory molecules MHC-II and CD80/86, when com-
pared to the non-stimulated control (Figure 1C) indicating
that these immunobiotic microorganisms were able to acti-
vate APCs. In all cases the MIF values in Lr1505-treated
cells almost doubled the MIF presented by control cells
(Figure 1C). APCs were similarly modulated by Lr1506
Figure 1 Effect of immunobiotic lactobacilli in porcine intestinal epithelial (PIE) cells and antigen presenting cells (APCs) from Peyer’s
patches. Monocultures of PIE cells or adherent cells from Peyer’s patches were stimulated with Lactobacillus rhamnosus CRL1505 (Lr1505) or
L. rhamnosus CRL1506 (Lr1506). The mRNA expression of IFN-α, IFN-β, IL-6, MCP-1 and TNF-α was studied in PIE cells after 48 hours of stimulation
(A). The mRNA expression of IFN-α, IFN-β, IL-1β, TNF-α, IFN-γ, IL-6, IL-2, IL-12, IL-10 and TGF-β was studied in adherent cells after 12 hours of
stimulation (B). Cytokine mRNA levels were calibrated by the swine β-actin level and normalized by common logarithmic transformation. In
addition, expression of MHC-II and CD80/86 molecules (C) as well as intracellular levels of IL-1β, IL-10, IFN-γ and IL-10 (D) were studied in the
three populations of APCs within adherent cells defined with CD172a and CD11R1 markers. Values represent means and error bars indicate the
standard deviations. The results are means of 3 measures repeated 4 times with independent experiments. The mean differences among different
superscripts letters were significant at the 5% level.
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the levels of IL-1β, IL-6, IFN-γ, and IL-10 on the three
populations of adherent cells: CD172a+CD11R1−,
CD172a−CD11R1low and CD172a+CD11R1high (Figure 1D).
In CD172a+CD11R1− cells both strains Lr1505 and
Lr1506 slightly but significantly enhanced the post-
translational expression levels of IL-1β, IL-6, and IL-10,
while the IFN-γ levels remained unchanged (Figure 1D).In CD172a−CD11R1low cells, both strains had a similar
effect on the expression of IL-1β, IL-6 and IFN-γ,
whereas IL-10 levels were not modified. In contrast, in
CD172a−CD11R1high cells IL-10 protein levels were up-
regulated by both strains, being Lr1505 the strain which
showed the strongest stimulation (Figure 1D). In ad-
dition, IL-1β was modulated only by Lr1505 but neither
IL-6 nor IFN-γ levels were affected by the stimulation of
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These results correlated with the mRNA expression
profiles shown before (Figure 1B).
Lactobacilli influence mRNA expression of type I IFN and
inflammatory cytokines in PIE cells after poly(I:C) challenge
In order to investigate whether Lr1505 and Lr1506 were
able to modify PIE cells response to a viral challenge, we
used the dsRNA analogue poly(I:C) to stimulate PIE cells
after pre-incubating them with the respective Lactobacillus
strains. Interestingly, PIE cells reacted differently towards
the single L. rhamnosus strains. Both Lr1505 and Lr1506
were able to significantly up-regulate the mRNA expres-
sion of IFN-α and IFN-β after poly(I:C) challenge. How-
ever, as depicted in Figure 2, while Lr1506 had a stronger
effect on the production of type I interferons, Lr1505 had a
higher influence on IL-6 mRNA expression. In addition,
both strains equally increased the mRNA expression of
TNF-α in poly(I:C)-challenged PIE cells while no signifi-
cant effect was observed on the mRNA expression of
MCP-1 at any time tested (Figure 2).
Lactobacilli activate APCs and differentially modulate the
expression of cytokines and activation markers in
response to poly(I:C)
We next evaluated the capacity of Lr1505 and Lr1506 to
modulate the antiviral response triggered by poly(I:C)
stimulation in adherent cells. Using this in vitro model,
which mimics de context of intestinal viral infection we
proved that lactobacilli not only modulated the response
of PIE cells but also modulated several cytokines tran-
scripts in immune adherent cells from PPs (Figure 3). As
expected, poly(I:C) challenge induced an increase in the
transcriptional levels of almost all cytokines tested in ad-
herent cells. Lr1505 and Lr1506 exerted in general an im-
provement in the mRNA expression of cytokines in
response to poly(I:C) challenge (Figure 3A). IL-1β, TNF-α,
IFN-γ, IL-2, IL-12, and IL-10 mRNA levels wereFigure 2 Effect of immunobiotic lactobacilli in the response of porcin
Monocultures of PIE cells were stimulated with Lactobacillus rhamnosus CR
challenged with poly(I:C). The mRNA expression of IFN-α, IFN-β, IL-6, MCP-1
challenge. Cytokine mRNA levels were calibrated by the swine β-actin leve
represent means and error bars indicate the standard deviations. The result
experiments. The mean differences among different superscripts letters wesignificantly higher in lactobacilli-treated cells than in
controls while the mRNA expression of IFN-α, IFN-β
and TGF-1β was not modified by Lr1505 or Lr1506
(Figure 3A). In addition, we observed that both strains
were equally effective to improve mRNA expression of
all the mentioned cytokines with the exception of IFN-γ
and IL-12 which were significantly higher in Lr1505-
treated cells when compared with those stimulated with
Lr1506 (Figure 3A).
In parallel experiments using the same stimulation
protocols, we studied the expression of surface activa-
tion markers and protein cytokine levels by flow cyto-
metry in CD172a+CD11R1−, CD172a−CD11R1low and
CD172a+CD11R1high adherent cells (Figure 3B). Chal-
lenge with poly(I:C) significantly increased the expres-
sion of surface molecules MHC-II and CD80/86 in the
three populations of APCs. In addition, we observed
that lactobacilli-treated cells showed higher levels of
MHC-II and CD80/86 when compared to control cells
with the exception of CD80/86 in Lr1506-treated
CD172a+CD11R1high cells that was similar to controls
(Figure 3B). We also observed differences in the up-
regulation of both molecules when comparing Lr1505 and
Lr1506, since MCH-II levels in CD172a−CD11R1low and
CD172a+CD11R1high adherent cells and CD80/86 levels in
the three populations of APCs were higher in Lr1505-
treated cells than in those stimulated with Lr1506
(Figure 3B). We also observed an up-regulation of IL-
1β, IL-6, IL-10 and IFN-γ in poly(I:C) challenged APCs
(Figure 3B) after being treated with L. rhamnosus
strains. When studying the influence of lactobacilli on
the distinct populations of APCs, we observed a differen-
tial behaviour towards each cell group. IL-1β, IL-6 and
IFN-γ levels were significantly higher in lactobacilli-
treated CD172a−CD11R1low cells when compared to
controls. Moreover, Lr1505 was more efficient than
Lr1506 to up-regulate the levels of the three cytokines
in that cell population (Figure 3B). On the other hand,e intestinal epithelial (PIE) cells to poly(I:C) challenge.
L1505 (Lr1505) or L. rhamnosus CRL1506 (Lr1506) for 48 hours and then
and TNF-α was studied in PIE cells at different time points after
l and normalized by common logarithmic transformation. Values
s are means of 3 measures repeated 4 times with independent
re significant at the 5% level.
Figure 3 Effect of immunobiotic lactobacilli in porcine antigen presenting cells (APCs) from Peyer’s patches. (A) Monocultures of adherent
cells from Peyer’s patches were stimulated with Lactobacillus rhamnosus CRL1505 (Lr1505) or L. rhamnosus CRL1506 (Lr1506) for 12 hours and then
challenged with poly(I:C). The mRNA expression of IFN-α, IFN-β, IL-1β, TNF-α, IFN-γ, IL-6, IL-2, IL-12, IL-10 and TGF-β was studied after 12 hours of stimulation.
Cytokine mRNA levels were calibrated by the swine β-actin level and normalized by common logarithmic transformation. (B) In addition, expression of
MHC-II and CD80/86 molecules as well as intracellular levels of IL-1β, IL-10, IFN-γ and IL-10 were studied in the three populations of APCs within adherent
cells defined with CD172a and CD11R1 markers. Values represent means and error bars indicate the standard deviations. The results are means of 3
measures repeated 4 times with independent experiments. The mean differences among different superscripts letters were significant at the 5% level.
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treated CD172a+CD11R1− and CD172a+CD11R1high
cells when compared to controls. Moreover, Lr1505 was
more efficient than Lr1506 to up-regulate the levels of
IL-10 in both cell populations (Figure 3B).
Lactobacilli differentially modulate cytokine expression in
response to poly(I:C) challenge in APCs co-cultured with
PIE cells
Although the studies in PIE cells and adherent cells de-
monstrated the ability of Lr1505 and Lr1506 to modulate
the response to poly(I:C) challenge, these in vitro models
are simplified and may neglect the effect of cell–cell inter-
actions in a complex organic microenvironment, which
completely changes the resulting response. Then we used
an in vitro PPs model culture system to evaluate the effect
of both Lr1505 and Lr1506 more precisely. Co-cultures of
PIE and adherent cells were treated with Lr1505 or
Lr1506 and then stimulated with poly(I:C). mRNA expres-
sion of type I IFN and pro- and anti-inflammatory cyto-
kines were measured at different times post-stimulation as
shown in Figure 4. Changes induced by lactobacilli in PIE
cells co-cultured with adherent cells were similar to those
observed in PIE cells monocultures (data not shown). In
adherent cells, poly(I:C) challenge increased the mRNA
expression of INF-α, INF-β, and TNF-α and a significant
increase was seen only in hour 3 in cells stimulated with
Lr1505 whereas Lr1506 did not affected the mRNA ex-
pression of INF-α and TNF-α, and slightly influenced theFigure 4 Effect of immunobiotic lactobacilli in porcine antigen presen
intestinal epithelial (PIE) cells. PIE cells were co-cultured with adherent c
CRL1505 (Lr1505) or L. rhamnosus CRL1506 (Lr1506) for 12 hours. PIE-APCs
of IFN-α, IFN-β, IL-1β, TNF-α, IFN-γ, IL-6, IL-2, IL-12, IL-10 and TGF-β was stud
calibrated by the swine β-actin level and normalized by common logarithm
standard deviations. The results are means of 3 measures repeated 4 times
superscripts letters were significant at the 5% level.IFN-β levels at this single time point (Figure 4). In
addition, IL-1β, IFN-γ, IL-6, IL-2, and IL-12p40 were up-
regulated by lactobacilli treatments (Figure 4). IFN-γ, IL-6,
IL-2, and IL-12p40 up-regulation by both strains was sus-
tained over time as it could be observed after 3, 6 and
12 hours post-poly(I:C) challenge and interestingly, levels
of IFN-γ transcript in Lr1505-treated cells was signifi-
cantly higher than those observed in Lr1506-treated cells
at hour 3 (Figure 4). IL-10 was the only cytokine whose
up-regulation increased gradually reaching a maximum
level at hour 12 post-challenge. Lactobacilli-treated cells
showed significantly higher levels of IL-10 mRNA expres-
sion however, Lr1505 showed a higher capacity to up-
regulate IL-10 especially in the later time points studied
(Figure 4). TGF-β mRNA expression suffered no changes
at any time point tested (Figure 4). These results indicate
that APCs can be indirectly modulated by both lactobacilli
strains through their actions on IECs.
TLR2 but not TLR9 would be involved in the
immunoregulatory effect of lactobacilli
We next aimed to evaluate whether TLR2 and/or TLR9
were involved in the immunomodulatory capacities of
lactobacilli in PIE and adherent cells. Then, cells were
stimulated again with Lr1505 or Lr1506 in the presence
or absence of blocking anti-TLR2 or anti-TLR9 anti-
bodies (Figure 5A). When analyzing cytokines tran-
scripts in PIE cells, it was evident that neither TLR2 nor
TLR9 were involved in the up-regulation of type I IFNsting cells (APCs) from Peyer’s patches co-cultured with porcine
ells from Peyer’s patches and stimulated with Lactobacillus rhamnosus
co-cultures were then challenged with poly(I:C). The mRNA expression
ied at different time points after challenge. Cytokine mRNA levels were
ic transformation. Values represent means and error bars indicate the
with independent experiments. The mean differences among different
Figure 5 Role of toll-like receptor (TLR)-2 and TLR9 in the immunoregulatory effect of immunobiotic lactobacilli in porcine intestinal
epithelial (PIE) cells and antigen presenting cells (APCs) from Peyer’s patches. Monocultures of PIE cells or adherent cells from Peyer’s
patches were stimulated with Lactobacillus rhamnosus CRL1505 (Lr1505) or L. rhamnosus CRL1506 (Lr1506) with or without the addition of
anti-TLR2 or anti-TLR9 blocking antibodies. The mRNA expression of IFN-α, IFN-β, IL-6, MCP-1 and TNF-α was studied in PIE cells after 48 hours
of stimulation (A). The mRNA expression of IFN-α, IFN-β, IL-1β, TNF-α, IFN-γ, IL-6, IL-2, IL-12, IL-10 and TGF-β was studied in adherent cells after
12 hours of stimulation (A). Cytokine mRNA levels were calibrated by the swine β-actin level and normalized by common logarithmic transformation.
In addition, expression of MHC-II and CD80/86 molecules as well as intracellular levels of IL-1β, IL-10, IFN-γ and IL-10 (B) were studied in the three
populations of APCs within adherent cells defined with CD172a and CD11R1 markers. Values represent means and error bars indicate the standard
deviations. The results are means of 3 measures repeated 4 times with independent experiments. The mean differences among different superscripts
letters were significant at the 5% level.
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http://www.biomedcentral.com/1471-2180/14/126induced by Lr1505 and Lr1506. In contrast, in the pre-
sence of anti-TLR2 blocked the increase of IL-6 and
TNF-α transcripts induced by Lr1505 and Lr1506 in PIE
cells (Figure 5A). In addition, anti-TLR2 antibodies sig-
nificantly blocked the increase of IL-1β, IL-6, IFN-γ, and
IL-10 transcripts induced by Lr1505 and Lr1506 in PPsadherent cells while anti-TLR9 antibodies did not mo-
dified the immunomodulatory activities of lactobacilli
(Figure 5A). We confirmed the involvement of TLR2 but
not TLR9 in the activation of PPs adherent cells using flow
cytometry. In CD172a+CD11R1−, CD172a−CD11R1low and
CD172a+CD11R1high adherent cells the addition of anti-
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http://www.biomedcentral.com/1471-2180/14/126TLR2 significantly reduced the capacity of both Lr1505
and Lr1506 to up-regulate the expression of MHC-II,
CD80/86, IL-1β, IL-6, IFN-γ, and IL-10 (Figure 5B).
Finally we evaluate the role of TLR2 and TLR9 in the
modulation of the response against poly(I:C) challenge
induced by lactobacilli (Figure 6A). Again, anti-TLR2
antibodies blocked the increase of IL-6 and TNF-α tran-
scripts induced by Lr1505 and Lr1506 in PIE cells while
no modification was observed for type I IFNs mRNA ex-
pression (Figure 6A). In a similar setting but using PPs
APCs, the increase in transcriptional levels of IL-1β, IL-6,
IFN-γ, and IL-10 in poly(I:C)-challenged adherent cells
induced by lactobacilli was blocked when anti-TLR2 anti-
bodies were present in the medium (Figure 6A). In
addition, the ability of Lr1505 and Lr1506 to induce
higher levels of MHCII and CD80/86 in poly(I:C)-chal-
lenged adherent cells was significantly blocked with anti-
TLR2 antibodies (Figure 6B). Moreover, when studying
the expression of IL-6, IFN-γ, IL-1β and IL-10 at post-
translational levels in APCs stimulated with lactobacilli
and then challenged with poly(I:C), MIF values remained
at the same level of poly(I:C)-challenged control cells
if the medium was added with anti-TLR2 antibodies
(Figure 6B). In none of the experiments performed
here, anti-TLR9 antibodies exerted any kind of effect
on the expression of cytokines or molecules related to
the antigen presenting process (Figure 6B).
Discussion
Rotavirus represents one of the prevailing causes of in-
fectious gastroenteritis in humans worldwide [3,4,6]. An
initial and essential step in the viral infection cycle of
rotavirus is entering and replicating in IECs of the small
intestine [25]. IECs have been well defined as sentinels,
because they are the first cells which encounter micro-
organisms and are not only a physical barrier but they
recognize different types of PAMPs via PRRs, which are
selectively expressed on the cell surface, internal com-
partments or cytoplasm. Upon virus internalization,
dsRNA molecules are generated in infected cells [25].
These molecules are typical of many viral infections in-
cluding rotavirus. Viral dsRNA activate PRRs such as
TLR3, RIG-I, and MDA-5, which signal host cellular re-
sponses in order to try to control viral infection [25-27].
IFNs and IFN-regulated gene products are then synthe-
sized and play a key role in the host response for clea-
ring viruses. Type I together with type II IFNs are able
to limit rotavirus infection in vitro and their levels are
augmented in rotavirus-infected children and animals
[18,28,29]. Recently, it has been proposed that IFNs sig-
nalling is not only beneficial to the host, but it may also
enhance rotavirus replication at the first stages of infec-
tion [30]. Nevertheless, other in vivo studies have shown
a markedly increase in the virulence of certain strains ofrotavirus when IFNs signalling was blocked during infec-
tion [31]. Furthermore, the fact that rotavirus has
evolved mechanisms to manipulate IFNs signalling such
as the type I IFNs damping NSP1 protein [32], strongly
suggests that IFNs are crucial to limit infection. There-
fore, approaches aiming to modulate pathways leading
to IFNs production may provide valuable tools to in-
crease natural viral defence mechanisms. Herein we
show evidence of how IECs can be modulated by immu-
nobiotic L. rhamnosus in a strain-dependent fashion to
enhance antiviral responses. For instance, Lr1506 was a
stronger inducer of both IFN-α and IFN-β than Lr1505.
In addition, these strains primed PIE cells to respond to
the dsRNA analogue poly(I:C), as the cells responded
with a significantly stronger synthesis of mRNA enco-
ding for type I IFNs than non-treated cells. Moreover,
the exposition of IECs to Lr1506 resulted in a signifi-
cantly stronger up-modulation of type I IFNs mRNA ex-
pression than the treatment with Lr1505.
Although activation of PPRs signalling pathways, espe-
cially upon stimulation with their respective ligands have
been extensively studied, research on the specific effect
and modulation capability of probiotics including whole
live LAB is more recent and in general includes different
species of Gram-positive bacteria. We have reported
previously, the modulation of type I IFNs in PIE cells
by lactobacillus strains, specifically Lactobacillus casei
MEP221106 [23]. Other studies on type I IFN induction
and/or modulation by lactobacilli have only been reported
for professional immune cells such as macrophages, DCs
and PBMC but are rare for IECs. Furthermore, our results
using blocking anti-TLR2 and anti-TLR9 antibodies
ruled out the involvement of both TLR2 and TLR9 (the
classical TLRs associated to LAB recognition) in the
primary induction of type I IFNs or the enhancement
of IFN-α and -β synthesis upon poly(I:C) challenge in-
duced by Lr1505 and Lr1506 in PIE cells. Further stu-
dies are needed in order to find the PRRs involved in
the recognition of lactobacilli leading to IFN-α and
IFN-β expression in PIE cells.
IECs are able to initiate and in a minor extent to re-
gulate the immune response to bacteria and viruses [33]
being able to secrete several pro-inflammatory cytokines
such as MCP-1, IL-6 and TNF-α on stimulation by patho-
gens. Both Lr1505 and Lr1506 were able to induce IL-6
and TNF-α mRNA expression in PIE cells but not MCP-1.
This fact contrasts with a previous report about another
probiotic strain, L. casei CRL431, which induces MCP-1
in murine IECs, which may be explained as both a strain-
specific and/or a host-specific phenomenon [34]. In
addition, not all IEC lines (e.g.: Caco-2, HT29, T84) are
able to produce the same cytokine profile upon stimula-
tion, and therefore, there are contradictory reports on the
ability of lactobacilli and other Gram-positive commensal
Figure 6 Role of toll-like receptor (TLR)-2 and TLR9 in the immunoregulatory effect of immunobiotic lactobacilli in porcine intestinal
epithelial (PIE) cells and antigen presenting cells (APCs) from Peyer’s patches in response to poly(I:C). Monocultures of PIE cells or
adherent cells from Peyer’s patches were stimulated with Lactobacillus rhamnosus CRL1505 (Lr1505) or L. rhamnosus CRL1506 (Lr1506) with or
without the addition of anti-TLR2 or anti-TLR9 blocking antibodies. PIE and APCs were then challenged with poly(I:C). The mRNA expression of
IFN-α, IFN-β, IL-6, MCP-1 and TNF-α in PIE and the mRNA expression of IFN-α, IFN-β, IL-1β, TNF-α, IFN-γ, IL-6, IL-2, IL-12, IL-10 and TGF-β in adherent cells
was studied after 12 hours of poly(I:C) challenge (A). Cytokine mRNA levels were calibrated by the swine β-actin level and normalized by
common logarithmic transformation. In addition, expression of MHC-II and CD80/86 molecules as well as intracellular levels of IL-1β, IL-10, IFN-γ
and IL-10 (B) were studied in the three populations of APCs within adherent cells defined with CD172a and CD11R1 markers. Values represent
means and error bars indicate the standard deviations. The results are means of 3 measures repeated 4 times with independent experiments.
The mean differences among different superscripts letters were significant at the 5% level.
Villena et al. BMC Microbiology 2014, 14:126 Page 11 of 14
http://www.biomedcentral.com/1471-2180/14/126bacteria to induce IL-6 in IECs. Thus, as already sug-
gested, this may be one advantage of working with IECs
primary cultures [34]. Vinderola et al. [34] reported induc-
tion of IL-6 by probiotic lactobacilli in normal murine
IECs as it was also the case for the effect on porcine IECs
reported in this study. Our results using anti-TLR2blocking antibodies proved that TLR2 is responsible for
the recognition of lactobacilli and induction of IL-6 and
TNF-α, which agrees with the results of Castillo et al. [35].
Dendritic cells are leading gatekeepers and regulators
of immunity, which are present in all tissues, especially
at the interface with the external environment, such as
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they play a fundamental role as they orchestrate the
subtle equilibrium between tolerance and protection
against infection [37]. We and others have reported that
probiotic lactobacilli are able to differentially stimulate
and modulate DCs in vitro [22,23,37-40]. Thus, we
wanted to study how the two immunobiotic L. rhamno-
sus strains reported here functionally modulate porcine
PPs-derived adherent immune cells (CD172a+CD11R1−,
CD172a−CD11R1low and CD172a+CD11R1high cells). The
main effect of incubating L. rhamnosus with the single
populations of immune adherent cells, resulted in dif-
ferential mRNA expression of the key polarizing cyto-
kines IL-1β, IL-6 and IFN-γ, which determine the fate
of naïve T-cells. Lr1505 was the strain with the highest
capacity to functionally modulate APCs. Considering
CD172a+CD11R1high and CD172a−CD11R1low cells as
DCs [21], and as such with the ability to favour Th1, Th2,
Th17 or Treg immune responses, the increases in both
IFN-γ and IL-12 induced especially by Lr1505, may lead
to a Th1 response if we extrapolate this data to an in vivo
situation. Furthermore, IFN-γ and IL-1β have been shown
to have a direct effect on IECs inducing an antiviral pro-
gram, which inhibits rotavirus entry [41,42].
On the other hand, Lr1505 also induced IL-10 mRNA
and protein expression, which is an immunoregulatory
cytokine that avoids inflammatory-tissue injury during in-
fections. Zhou et al. [43] provided direct evidence that aber-
rant activation of intestinal immunity induced by poly(I:C)
or purified rotavirus genomic dsRNA causes a breakdown
of the mucosal homeostasis, leading to mucosal damage.
Moreover, it was reported that the induction of the regula-
tory IL-10 plays an important role to control the inflamma-
tory process upon a viral infection to minimize tissue injury
[39,44]. Then, the improved production of IL-10 inducedFigure 7 Proposed mechanism for the immunoregulatory effect and
L. rhamnosus CRL1506 on porcine intestinal epithelial cells and antigeby Lr1505 in APCs after the challenge with poly(I:C) could
have an important protective effect during intestinal viral
infections.
It is well known that commensal microbiota interacts
with cells of the intestinal mucosa via TLR [36] but not all
bacteria have the ability to modulate immune responses,
as this is a strain specific characteristic. As lactobacilli
may be recognized by APCs through the peptidoglycan
and lipoteichoic acid in their cell walls and/or CpG motifs
in their DNA, we used anti-TLR2 and anti-TLR9 anti-
bodies to block recognition via the respective receptors in
order to elucidate whether they were responsible for the
observed immunoregulatory activity of lactobacilli in
APCs. TLR2 is one of the PRRs that would be of great im-
portance for the immunomodulatory effect of probiotic
microorganisms in APCs. Immunoenhancing lactobacilli
are able to increase the expression of TLR2 in DCs and
macrophages isolated from PPs in mice [45] and in human
myeloid DCs [46]. Moreover, Weiss et al. [40] reported a
TLR2-dependent mechanism for L. acidophilus NCFM,
whose IFN-β expression was markedly reduced in TLR-2
−/− DCs. In our experiments, the main effect observed on
type I IFNs was observed in PIE cells and not in immune
cells. After the challenge of APCs with poly(I:C), we ob-
served a weak enhancement of type I IFNs mRNA expres-
sion, which was only 3 h after stimulation and therefore
was not further studied. On the contrary, we observed a
clear involvement of TLR2 signalling pathway in the up-
modulation of IL-1β, IL-6, IL-10 and IFN-γ in APCs
exerted by both L. rhamnosus strains alone and following
a poly(I:C) challenge. In addition, the lactobacilli reported
by Plantinga et al. [47] induced cytokines in DCs in a
TLR9-dependent manner, contrasting our results which
show no relationship between TLR9 and the immuno-
regulatory effect of Lr1505 or Lr1506.antiviral activities of Lactobacillus rhamnosus CRL1505 and
n-presenting cells from swine Peyer’s patches.
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There is a general concept that the overall effect of pro-
biotics is strain-specific, but there are only a few compara-
tive studies where at least two strains of the same species
provide significant differences in their immunomodulatory
potential [38]. Herein, we show that two strains, both
L. rhamnosus, isolated from the same ecological niche and
with similar technological properties [10,11], are capable
to induce differential antiviral defence phenotypes in IECs
and APCs. We propose a model of action for each strain
as depicted in Figure 7. In general terms, Lr1506 has a
marked influence on IECs and antiviral innate defence
mediated by type I IFNs, whereas Lr1505 stands out for
its influence on APCs.
Both Lr1505 and Lr1506 were able to induce IFN–α
and –β mRNA expression in IECs and improve the pro-
duction of type I IFNs in response to poly(I:C) challenge
independently of TLR2 or TLR9 signalling. However,
Lr1506 showed a higher capacity to improve levels of
IFN-α and IFN-β in IECs when compared with Lr1505,
which is in line with our previously reported in vivo re-
sults, showing higher levels of IFN-α and IFN-β in intes-
tinal fluids of Lr1506-treated than in Lr1505-treated
mice [16]. Considering that type I IFNs up-regulate sev-
eral genes involved in viral defence and genes of major
importance for the development of a strong cellular re-
sponse, we hypothesize that Lr1506 may play an import-
ant role in the improvement of innate immune responses
against intestinal virus, especially in IECs.
In addition, both lactobacilli induced expression of IL-
6 and TNF-α via TLR2 in IECs, being Lr1505 the stron-
ger modulator of these cytokines. Furthermore, although
both strains were able to significantly increase surface
molecules expression and cytokine production in intes-
tinal APCs, Lr1505 had a stronger effect both when
applied alone or combined with a posterior poly(I:C)
challenge. The improved Th1 response induced by Lr1505
was triggered by TLR2 signalling and included augmented
expression of MHC-II and co-stimulatory molecules and
expression of IL-1β, IL-6, and IFN-γ in APCs (Figure 7).
Considering that TLR signalling is a crucial aspect of
innate defence [48,49], but if uncontrolled at mucosal
surfaces, it would be pathological, it is important to
highlight again the fact that IL-10 was also significantly
up-regulated by Lr1505, suggesting that the inflamma-
tory conditions may be held under control (Figure 7).
These in vitro results are in line with our previous findings
showing that Lr1505 was more efficient than Lr1506 for
increasing the levels of IFN-γ, IL-10 and IL-6 in the intes-
tine of mice [16].
It was recently reviewed the emergence of TLR agonists
as new ways to transform antiviral treatments by introdu-
cing panviral therapeutics with less adverse effects than
IFN therapies [50]. The use of L. rhamnosus CRL1505 andL. rhamnosus CRL1506 as modulators of innate immunity
and inductors of antiviral type I IFNs, IFN-γ, and regula-
tory IL-10 clearly offers the potential to overcome this
challenge. To evaluate in vitro and in vivo the capacity of
both strains to protect against rotavirus infection is an in-
teresting topic for future research.
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